News Conference News TCT 2025 Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions Todd Neale October 26, 2025
News Daily News Dual Approach the Best Remedy for Aortic Stenosis, Amyloidosis: Registry Caitlin E. Cox June 09, 2025
News Conference News SCAI 2025 Medicare Analysis Reassures on PCI in Ambulatory Surgery Centers L.A. McKeown May 07, 2025
News Conference News CX Symposium 2025 Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK L.A. McKeown April 24, 2025
News Conference News CX Symposium 2025 Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices L.A. McKeown April 23, 2025
News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Opinion Conversations in Cardiology All Eyes on PCI—Should Patients’ Family Members Watch Cases? December 19, 2024
News Conference News VIVA 2024 DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years L.A. McKeown November 11, 2024
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024
News Conference News TCT 2024 SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD L.A. McKeown October 29, 2024
News Conference News TCT 2024 ECLIPSE: Orbital Atherectomy No Better Than Balloon Angioplasty in Calcified Lesions Yael L. Maxwell October 29, 2024
News Daily News ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI Michael O'Riordan July 01, 2024
News Conference News EuroPCR 2024 Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT Michael O'Riordan May 28, 2024
News Conference News EuroPCR 2024 Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS Yael L. Maxwell May 15, 2024
News Conference News CRT 2024 Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries L.A. McKeown March 14, 2024
News Daily News Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis L.A. McKeown March 01, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024